Literature DB >> 16088792

Incidence and burden of rotavirus gastroenteritis in Japan, as estimated from a prospective sentinel hospital study.

Toyoko Nakagomi1, Osamu Nakagomi, Yoshihiro Takahashi, Masamichi Enoki, Takashi Suzuki, Paul E Kilgore.   

Abstract

We assessed the burden of rotavirus infection-related disease, in terms of hospitalization and associated costs, at 3 sentinel hospitals in Akita prefecture, Japan. From January 2001 through December 2002, a total of 443 children <5 years of age were hospitalized for acute gastroenteritis. Of 422 stool specimens collected, 244 (58%) tested positive for rotavirus. Only 7.8% of the rotavirus disease-associated hospitalizations involved infants <6 months of age, whereas most cases of disease (39%) were reported in the second year of life, and 89% of cases had occurred by 36 months of age. The mean severity score for rotavirus gastroenteritis resulting in hospitalization was 16.5, according to the modified 20-point severity scoring system. The average associated direct medical cost was 136,000 yen (1236 US dollars) per case and was similar among the 3 hospitals. The estimated incidence of rotavirus disease-associated hospitalizations among children <5 years of age was 7.9-17.6 hospitalizations/1000 person-years, and the estimated cumulative incidence by 5 years of age was 6.6%. Thus, approximately 1 in 15 children will require hospitalization due to rotavirus diarrhea by their fifth year of life. In Japan, this would mean that 78,000 children <5 years of age would be hospitalized each year, resulting in a direct medical cost of 10 billion yen (96 US dollars million). The burden associated with rotavirus gastroenteritis in Japan is substantial and might be reduced through the introduction of vaccines.

Entities:  

Mesh:

Year:  2005        PMID: 16088792     DOI: 10.1086/431503

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

1.  Cost-effectiveness of rotavirus vaccination in Bolivia from the state perspective.

Authors:  Emily R Smith; Emily E Rowlinson; Volga Iniguez; Kizee A Etienne; Rosario Rivera; Nataniel Mamani; Rick Rheingans; Maritza Patzi; Percy Halkyer; Juan S Leon
Journal:  Vaccine       Date:  2011-09-02       Impact factor: 3.641

2.  Economic evaluation of routine infant rotavirus immunisation program in Japan.

Authors:  Shu-Ling Hoshi; Masahide Kondo; Ichiro Okubo
Journal:  Hum Vaccin Immunother       Date:  2016-10-20       Impact factor: 3.452

3.  Rotavirus infections and climate variability in Dhaka, Bangladesh: a time-series analysis.

Authors:  M Hashizume; B Armstrong; Y Wagatsuma; A S G Faruque; T Hayashi; D A Sack
Journal:  Epidemiol Infect       Date:  2007-11-08       Impact factor: 2.451

4.  Prevalence of G2P[4] and G12P[6] rotavirus, Bangladesh.

Authors:  Mustafizur Rahman; Rasheda Sultana; Giasuddin Ahmed; Sharifun Nahar; Zahid M Hassan; Farjana Saiada; Goutam Podder; Abu S G Faruque; A K Siddique; David A Sack; Jelle Matthijnssens; Marc Van Ranst; Tasnim Azim
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

5.  Active, population-based surveillance for rotavirus gastroenteritis in Chinese children: Beijing Municipality and Gansu Province, China.

Authors:  Jing Zhang; Haixia Liu; Lei Jia; Daniel C Payne; Aron J Hall; Ziqian Xu; Zhiyong Gao; Zhaorui Chang; Baoming Jiang; Umesh D Parashar; Lei Meng; Hongjie Yu; Zhaojun Duan
Journal:  Pediatr Infect Dis J       Date:  2015-01       Impact factor: 2.129

6.  Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): A prospective community-based study.

Authors:  Martin Sénécal; Marc Brisson; Marc H Lebel; John Yaremko; Richard Wong; Lee Ann Gallant; Hartley A Garfield; Darryl J Ableman; Richard L Ward; John S Sampalis; James A Mansi
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-11       Impact factor: 2.471

7.  Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection.

Authors:  Daisuke Tokuhara; Beatriz Álvarez; Mio Mejima; Tomoko Hiroiwa; Yuko Takahashi; Shiho Kurokawa; Masaharu Kuroda; Masaaki Oyama; Hiroko Kozuka-Hata; Tomonori Nochi; Hiroshi Sagara; Farah Aladin; Harold Marcotte; Leon G J Frenken; Miren Iturriza-Gómara; Hiroshi Kiyono; Lennart Hammarström; Yoshikazu Yuki
Journal:  J Clin Invest       Date:  2013-08-08       Impact factor: 14.808

8.  Differential and enhanced response to climate forcing in diarrheal disease due to rotavirus across a megacity of the developing world.

Authors:  Pamela P Martinez; Aaron A King; Mohammad Yunus; A S G Faruque; Mercedes Pascual
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

9.  Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil.

Authors:  Ricardo Q Gurgel; Luis E Cuevas; Sarah C F Vieira; Vanessa C F Barros; Paula B Fontes; Eduardo F Salustino; Osamu Nakagomi; Toyoko Nakagomi; Winifred Dove; Nigel Cunliffe; Charles A Hart
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883

10.  Healthcare-associated viral gastroenteritis among children in a large pediatric hospital, United Kingdom.

Authors:  Nigel A Cunliffe; J Angela Booth; Claire Elliot; Sharon J Lowe; Will Sopwith; Nick Kitchin; Osamu Nakagomi; Toyoko Nakagomi; C Anthony Hart; Martyn Regan
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.